Skip to main content
Fig. 6 | Clinical Epigenetics

Fig. 6

From: Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma

Fig. 6

a Induced demethylation was recognized with the increased band intensity of the amplicons against the unmethylation (U)-specific primers in AZA-treated SF-767 cell line. b The adjacent bar chart, extracted from the gel image expresses the change in demethylation ratio between the non-treated and AZA-treated replica. The demethylation ratio at each of the subtelomeres was increased in comparison to the untreated replica. Nonetheless, we did not observe any significant alteration in TL after treatment with AZA (c).

Back to article page